Laura Certain received a B.A. in Chemistry from Princeton University in 2000, followed by an M.D. and Ph.D. in Genome Sciences from the University of Washington, Seattle. For her graduate work she studied the emergence of drug resistance in Plasmodium falciparum, the parasite that causes the most aggressive form of malaria. She moved to Boston in 2009 for Internal Medicine residency training at Massachusetts General Hospital, during which she encountered innumerable patients with multi-drug resistant infections. After completing residency in 2012 she continued her clinical training as an Infectious Disease Fellow at MGH and Brigham & Women’s Hospital. She became a Wyss Clinical Fellow in 2013, joining Jim Collins’ group to study drug resistance in bacteria. She aims to increase our understanding of how bacteria respond to antibiotic treatment so that we can use antibiotics more intelligently.